title: Recombinant von Willebrand factor.
authors.affiliation: Immuno AG, Vienna, Austria.
authors.forename: H P
authors.initials: HP
authors.lastname: Schwarz
authors.forename: P L
authors.initials: PL
authors.lastname: Turecek
authors.forename: L
authors.initials: L
authors.lastname: Pichler
authors.forename: A
authors.initials: A
authors.lastname: Mitterer
authors.forename: W
authors.initials: W
authors.lastname: Mundt
authors.forename: F
authors.initials: F
authors.lastname: Dorner
authors.forename: J
authors.initials: J
authors.lastname: Roussi
authors.forename: L
authors.initials: L
authors.lastname: Drouet
mesh_terms: D000818:Animals; D003894:Deamino Arginine Vasopressin / Q000627:therapeutic use*; D004285:Dogs; D004359:Drug Therapy, Combination; D005169:Factor VIII / Q000627:therapeutic use*; D006801:Humans; D051379:Mice; D011994:Recombinant Proteins / Q000627:therapeutic use; D013552:Swine; D014842:von Willebrand Diseases / Q000188:drug therapy*; D014841:von Willebrand Factor / Q000627:therapeutic use*
chemical_list: D011994:Recombinant Proteins; D014841:von Willebrand Factor; D005169:Factor VIII; D003894:Deamino Arginine Vasopressin